Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
Anne Camirand(McGill University Health Centre), Michaël Pollak(McGill University)
Cited by 121
Related Papers
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
|The Lancet|1998|1.8k
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
|Cancer Research|2006|1k
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
|Nature Medicine|2014|664
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
|The Lancet Oncology|2015|380